X4 Pharmaceuticals Inc's Suppliers Performance

Name: X4 Pharmaceuticals Inc's (XFOR) Suppliers by Company, Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

XFOR's Supply Chain

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


XFOR Costs vs Sales of Suppliers Growth		X4 Pharmaceuticals Inc's cost of sales deteriorated by -87.32 % year on year, sequentially cost of sales grew by 64.29 % in Q1. • More on XFOR Suppliers

X4 Pharmaceuticals Inc's cost of sales deteriorated by -87.32 % year on year, sequentially cost of sales grew by 64.29 % in Q1.

• More on XFOR Suppliers

Select the Relationship:

Suppliers ▼

Select the Category:

Comparison ▼

Suppliers ▼

Basic Report▼

X4 Pharmaceuticals Inc's Comment on Supply Chain

The company sources active pharmaceutical ingredients (API) and finished drug products through third-party contractors who undergo a formal qualification process. It has a master services agreement with Evotec A.G. (formerly Aptuit, Oxford) for manufacturing the API mavorixafor. Additionally, the company maintains a master services agreement with Catalent Inc., which serves as the sole manufacturer of the final capsule drug product formulation of mavorixafor. This agreement with Catalent Inc. is set to expire on December 31, 2028, and includes specified termination clauses. The company ensures compliance with current Good Manufacturing Practices (cGMPs) and other global regulations by relying on contract manufacturers for production of compounds used in clinical trials and distribution. This approach enables the company to allocate resources toward development and commercialization rather than manufacturing infrastructure.

X4 Pharmaceuticals Inc's Comment on Supply Chain

XFOR's Stock Perfrormance relative to it's Suppliers

XFOR's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
X4 Pharmaceuticals Inc	510.21	9.01	-99.72	45
SUBTOTAL	0.00	0.00	0.00	-

Sources: X4 Pharmaceuticals Inc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, August 29, 2026 5:39 PM
For your research, we’ve provided nine additional tables on X4 Pharmaceuticals Inc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.